Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Amir R. Afshari, Hamid Mollazadeh, Elmira Mohtashami, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 2, pp. 377-400
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Effects of statins on brain tumors: a review
Amir R. Afshari, Hamid Mollazadeh, Neil C. Henney, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 116-133
Open Access | Times Cited: 69
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Amir R. Afshari, Mehdi Sanati, Hamid Mollazadeh, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 860-872
Closed Access | Times Cited: 54
Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress
Mehdi Sanati, Amir R. Afshari, Prashant Kesharwani, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 287-304
Closed Access | Times Cited: 50
Zerumbone Promotes Cytotoxicity in Human Malignant Glioblastoma Cells through Reactive Oxygen Species (ROS) Generation
Mohammad Jalili‐Nik, Mohammad Montazami Sadeghi, Elmira Mohtashami, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 55
Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions
Abolfazl Maghrouni, Maryam Givari, Mohammad Jalili‐Nik, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107403-107403
Closed Access | Times Cited: 40
Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases
Sajad Abolfazli, Sercan Karav, Thomas P. Johnston, et al.
Pharmacological Reports (2025)
Closed Access
A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules
Amir R. Afshari, Mehdi Sanati, Samaneh Aminyavari, et al.
Inflammopharmacology (2025)
Closed Access
Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation
Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113740-113740
Open Access | Times Cited: 24
Superoxide dismutase: a key target for the neuroprotective effects of curcumin
Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 3, pp. 693-705
Closed Access | Times Cited: 14
Tumor-Inhibitory Effects of Zerumbone Against HT-29 Human Colorectal Cancer Cells
Fezzeh Memari, Farshad Mirzavi, Mohammad Jalili‐Nik, et al.
International Journal of Toxicology (2022) Vol. 41, Iss. 5, pp. 402-411
Closed Access | Times Cited: 18
Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166720-166720
Closed Access | Times Cited: 11
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri, et al.
Current Medicinal Chemistry (2021) Vol. 28, Iss. 24, pp. 4877-4892
Open Access | Times Cited: 25
Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro
Mohammad Jalili‐Nik, Amir R. Afshari, Hamed Sabri, et al.
BioFactors (2021) Vol. 47, Iss. 5, pp. 729-739
Closed Access | Times Cited: 24
Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Bahram Bibak, Farzaneh Shakeri, Zakieh Keshavarzi, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 26, pp. 4507-4528
Open Access | Times Cited: 17
The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
Elmira Mohtashami, Negar Shafaei-Bajestani, Hamid Mollazadeh, et al.
Current Drug Metabolism (2020) Vol. 21, Iss. 8, pp. 564-578
Closed Access | Times Cited: 26
<p>LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma</p>
Bin Zhu, Wei Liu, Hongliang Liu, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6511-6521
Open Access | Times Cited: 25
How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme
Mehdi Sanati, Samaneh Aminyavari, Hamid Mollazadeh, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 2, pp. 323-339
Closed Access | Times Cited: 14
<p>Cytotoxic and Antiproliferative Effects of β-Mangostin on Rat C6 Glioma Cells Depend on Oxidative Stress Induction via PI3K/AKT/mTOR Pathway Inhibition</p>
Kaiqiang Li, Lingling Wu, Yili Chen, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5315-5324
Open Access | Times Cited: 22
Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres
Hossein Javid, Amir R. Afshari, Farnaz Zahedi Avval, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 19
Urolithin B loaded in cerium oxide nanoparticles enhances the anti-glioblastoma effects of free urolithin B in vitro
Ghasem Rahimi-Kalateh Shah Mohammad, Alireza Motavalizadehkakhky, Majid Darroudi, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 78, pp. 127186-127186
Closed Access | Times Cited: 7
Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic
Amir R. Afshari, Hamid Mollazadeh, Amirhossein Sahebkar
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 18
Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: in-vitro study
Mostafa Karimi Roshan, Amir R. Afshari, Farshad Mirzavi, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 6
Dietary anethole: a systematic review of its protective effects against metabolic syndrome
Fatemeh Dehbashizadeh Torghabeh, Behjat Javadi, Amirhossein Sahebkar
Journal of Diabetes & Metabolic Disorders (2023) Vol. 23, Iss. 1, pp. 619-631
Closed Access | Times Cited: 5
Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions
Hamid Mollazadeh, Elmira Mohtashami, Seyed Hadi Mousavi, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 37, pp. 4777-4788
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top